What term describes monitoring medication performance after it is released to the market?

• A. Post-Market Surveillance
• B. Black Box Warnings
• C. Orphan Drugs
• D. Labeled Indications

Answer: (A)

Monitoring a drug after it hits the market is about watching its safety and performance in real-world use, catching rare or long-term adverse effects, and continually reassessing risk and benefit as more data come in. This ongoing process is Post-Market Surveillance, often encompassed in pharmacovigilance activities. It involves collecting adverse event reports, analyzing trends, and sometimes prompting labeling changes or new safety measures to protect patients.

Black Box Warnings are the strictest safety notes on labeling about serious risks; Orphan Drugs refer to treatments for rare diseases with special incentives; Labeled Indications are the approved uses listed on the product label. None of these describe the ongoing monitoring process itself.